No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
598 |
4. Check minimum number of eventsNone |
598 |
5. Include endpointsNone |
598 |
6. Filter based on genotype QC (FinnGen only) |
598 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF10
Mandibular prognathia
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10540 | 4767 | 5746 |
| Only index persons | 9023 | 4093 | 4930 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.14 | 0.16 |
| Only index persons | 0.17 | 0.15 | 0.19 |
| Median age at first event (years) | |||
| Whole population | 13.23 | 13.24 | 13.15 |
| Only index persons | 14.49 | 14.49 | 14.49 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 598 | 354 | 244 |
| Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.11 |
| Median age at first event (years) | 30.51 | 29.12 | 32.52 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 514
- Matched controls
- 5138
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
+∞
323.0
514
*
K07.14
ICD-10 Finland
Retrognaty, maxillary
198.5
182.4
181
14
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
32.2
164.0
224
120
SBB10
NOMESCO Finland
Teeth copy
16.4
163.2
317
458
EEC05
NOMESCO Finland
Le Fort I osteotomy
237.6
127.0
126
7
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
16.0
112.6
198
193
EB1MA
NOMESCO Finland
Cephalometry with X-ray
15.0
109.7
199
207
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
14.5
104.8
193
205
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
12.9
95.6
186
217
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
165.9
92.6
95
7
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
14.2
88.3
161
160
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
13.3
86.6
163
173
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
13.6
85.1
158
162
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
8.9
77.3
188
314
SAA04
NOMESCO Finland
Special inverstigation of mouth
9.3
73.6
171
262
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
9.9
70.1
154
212
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
15.5
69.9
120
99
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
9.6
66.8
149
209
K07.10
ICD-10 Finland
Asymmetry of jaw
102.8
65.8
71
8
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
12.5
63.3
120
122
K07.24
ICD-10 Finland
Open bite
22.3
59.6
88
47
SAA03
NOMESCO Finland
Extended examination of mouth
4.3
51.6
371
1920
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
9.9
51.1
109
136
SJC00
NOMESCO Finland
Bracket with fixed attachment
86.1
49.0
54
7
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
184.1
48.8
50
*
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
6.3
46.0
136
276
K07.13
ICD-10 Finland
Retrognaty, mandibular
13.9
44.9
79
66
SXC05
NOMESCO Finland
Other oral or dental procedure
5.3
42.7
151
377
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
148.1
39.3
41
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
6.1
38.4
114
228
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
6.4
37.4
106
199
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
7.1
36.6
96
162
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.3
36.5
317
1679
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
6.6
35.0
96
172
SJB60
NOMESCO Finland
External device grinding and adaptation
7.2
34.3
88
143
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
96.6
33.2
36
*
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
124.9
33.1
35
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.1
32.5
264
1293
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
77.0
32.3
36
5
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
32.5
32.2
42
14
K07.60
ICD-10 Finland
Snapping jaw
7.3
31.5
79
124
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
117.3
31.0
33
*
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
5.6
30.6
96
202
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
38.6
28.7
36
10
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
5.4
27.5
89
193
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
5.6
27.3
85
176
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
6.8
27.2
72
121
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
4.4
25.9
102
272
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
142.2
25.9
27
*
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
+∞
24.1
23
*
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
7.8
23.8
56
79
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
4.4
22.1
86
225
K00.00
ICD-10 Finland
Hypodontia
10.0
20.5
41
44
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
207.6
19.7
20
*
EBB10
NOMESCO Finland
Insertion of dental implant
14.8
19.3
32
23
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
14.8
19.3
32
23
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
5.5
17.6
53
105
EB1WA
NOMESCO Finland
NA
24.0
16.6
23
10
SJA02
NOMESCO Finland
Plan for orthodontic care
87.8
15.7
17
*
SXC03
NOMESCO Finland
Other oral or dental procedure
14.7
14.7
24
17
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
13.8
85
316
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
10.9
13.4
25
24
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
10.1
13.4
26
27
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
11.4
13.1
24
22
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
13.5
13.0
22
17
EBB15
NOMESCO Finland
Insertion of dental implant abutment
19.7
13.0
19
10
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
6.1
12.9
35
61
SPB10
NOMESCO Finland
Production of temporary crone to tooth
21.9
12.1
17
8
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
10.9
11.9
22
21
SAA01
NOMESCO Finland
Simple examination of mouth
2.1
11.7
399
3210
SAA02
NOMESCO Finland
Basic examination of mouth
2.1
11.5
408
3316
Z3229
NOMESCO Finland
Other healthcare associate professional
3.0
11.5
67
241
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
8.6
11.4
24
29
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
4.9
11.3
36
77
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.9
149
839
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
18.3
10.8
16
9
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
22.0
10.7
15
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
10.3
37
90
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
3.4
10.2
49
153
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
11.6
10.1
18
16
K07.4
ICD-10 Finland
Malocclusion, unspecified
6.2
9.9
26
44
WZA90
NOMESCO Finland
Other doctors statement
2.0
9.8
153
902
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
6.4
9.8
25
41
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
10.3
9.6
18
18
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.4
9.2
45
143
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.6
9.2
70
295
K07.04
ICD-10 Finland
Macrognathism (mandibular)(maxillary)
50.9
8.7
10
*
K01.0
ICD-10 Finland
Embedded teeth
5.3
8.6
25
49
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
8.3
93
473
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
12.0
8.1
14
12
WX110
NOMESCO Finland
Local anesthesy
1.8
8.0
369
3028
EBA00
NOMESCO Finland
Extraction of tooth
1.8
7.9
200
1371
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
9.6
7.8
15
16
OIKK
NOMESCO Finland
NA
2.5
7.8
59
249
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
45.7
7.7
9
*
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
12.1
7.6
13
11
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.2
7.5
77
376
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
7.0
7.3
17
25
EDC30
NOMESCO Finland
Genioplasty
+∞
7.3
7
*
EEC02
NOMESCO Finland
Rapid expansion of maxilla
+∞
7.3
7
*
K07.23
ICD-10 Finland
Deep bite
2.7
7.3
49
192
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
7.2
151
970
K07.26
ICD-10 Finland
Anomalies of dental arch relationship
20.3
7.2
10
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
7.0
36
121
SDA02
NOMESCO Finland
Parodonthologic therapy
1.7
6.8
182
1261
SPC40
NOMESCO Finland
Preparation of first or second intermediate attachment tooth for bridge
22.8
6.7
9
*
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
22.8
6.7
9
*
F45.8
ICD-10 Finland
Other somatoform disorders
2.6
6.6
46
185
ZXA10
NOMESCO Finland
Bilateral
2.0
6.5
84
454
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
2.5
6.5
48
200
ZXX07
NOMESCO Finland
Extent of procedure, 7 units
70.7
6.4
7
*
ECW06
NOMESCO Finland
Insertion of mini-implant or miniscrew
+∞
6.3
6
*
K07.29
ICD-10 Finland
Anomaly in the relationship between the tooth arches UNS
+∞
6.3
6
*
K05.30
ICD-10 Finland
Periodontitis complex
2.3
6.2
56
260
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
50
230
2.28
6.49
2.9
3.1
ng/l
130.6
147.2
0.12
44
210
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
246
1974
1.42
4.13
7.3
7.7
mmol/l
1.2
1.2
1.78
214
1727
(3013826) Glucose [Moles/volume] in Serum or Plasma
297
2495
1.38
3.67
4.7
4.9
mmol/l
6.5
6.4
0.18
275
2271
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
476
4377
1.43
3.09
4.9
4.4
mu/l
1.8
2.1
0.58
443
4077
(3019897) Erythrocyte distribution width [Ratio] by Automated count
16
62
2.62
3.06
1.9
1.6
%
13.2
13.1
0.07
16
62
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
101
722
1.48
3.06
1.7
1.6
pmol/l
413.8
18483857.8
0.79
86
633
(3032080) INR in Blood by Coagulation assay
176
1397
1.37
2.97
9.0
6.1
inr
1.2
1.1
0.60
59
442
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
413
3730
1.35
2.84
4.3
3.8
pmol/l
14.5
14.5
0.15
382
3423
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
370
3302
1.32
2.69
6.0
6.8
u/l
78.8
83.3
0.67
354
3113
(3035350) Ketones [Presence] in Urine by Test strip
262
2236
1.31
2.63
3.6
3.3
estimate
0.0
0.0
0.00
38
453
(3009261) Glucose [Presence] in Urine by Test strip
265
2267
1.30
2.60
3.6
3.3
estimate
0.0
0.0
0.50
37
448
(3037467) Urinalysis macro (dipstick) panel - Urine
355
3158
1.31
2.60
4.5
4.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
472
4374
1.38
2.59
14.2
14.0
%
13.3
13.4
0.68
462
4292
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
160
1276
1.35
2.58
2.4
2.5
u/l
56.7
58.1
0.14
150
1194
(3021601) Nitrite [Presence] in Urine by Test strip
262
2243
1.30
2.54
5.0
4.6
estimate
0.0
0.0
0.00
39
465
(3021960) Folate [Moles/volume] in Serum or Plasma
109
822
1.40
2.48
1.4
1.4
nmol/l
19.1
20.8
0.68
93
710
(3036481) Cortisol [Moles/volume] in Serum or Plasma
66
453
1.51
2.45
2.5
2.2
nmol/l
416.4
364.0
0.44
61
421
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
248
2124
1.29
2.35
3.9
4.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
132
1041
1.34
2.27
3.7
3.1
kg/l
1.0
1.0
0.94
18
130
(3003327) Ova and parasites identified in Stool by Light microscopy
34
202
1.72
2.26
2.2
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
126
989
1.35
2.24
4.7
4.3
mg/mmol
9.2
11.9
0.27
76
672
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
137
1095
1.33
2.15
2.5
2.2
mg/l
2.5
2.8
0.82
122
958
(3013707) Erythrocyte sedimentation rate by Westergren method
371
3367
1.27
2.10
4.1
4.0
mm/h
9.2
9.4
0.14
351
3122
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
517
4906
1.40
2.09
12.1
11.1
mg/l
21.3
21.7
0.10
402
3634
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
416
3832
1.28
2.07
5.8
4.7
mmol/mol
38.5
38.5
0.02
398
3615
(3000494) Fungus identified in Specimen by Culture
68
490
1.44
2.01
1.3
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
194
1641
1.27
1.97
4.9
5.5
g/l
37.1
37.0
0.10
178
1542
(3019550) Sodium [Moles/volume] in Serum or Plasma
496
4687
1.34
1.97
13.5
12.1
mmol/l
139.6
139.6
0.13
489
4547
(3023103) Potassium [Moles/volume] in Serum or Plasma
497
4698
1.34
1.97
13.5
12.2
mmol/l
4.0
3.9
1.05
487
4540
(40765089) Chromosome analysis panel - Blood by G-banded
11
45
2.47
1.94
1.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
9
33
2.75
1.94
7.2
5.0
ug/l
1.1
1.8
—
9
33
(3031040) Bacteria [#/volume] in Urine by Automated count
327
2966
1.23
1.70
4.6
3.9
e6/l
319.1
915.3
—
7
40
(3003458) Phosphate [Moles/volume] in Serum or Plasma
81
621
1.35
1.69
7.8
8.2
mmol/l
1.1
1.1
0.85
71
588
(40768797) Stomach Pathology biopsy report
69
516
1.38
1.68
1.2
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
208
1806
1.23
1.64
7.1
7.4
mmol/l
1.2
1.2
0.84
185
1672
(3044889) 12 lead EKG panel
312
2824
1.22
1.63
3.3
3.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
442
4153
1.25
1.58
3.8
3.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
21
344
0.60
1.54
29.0
17.6
inr
1.2
1.2
—
5
54
(3016244) Insulin [Units/volume] in Serum or Plasma
17
93
1.85
1.53
3.9
3.0
mu/l
61.8
18.7
0.48
17
88
(3019309) Folate [Moles/volume] in Red Blood Cells
75
579
1.34
1.51
1.5
1.6
nmol/l
1188.1
1157.2
0.12
60
452
(3023520) Reticulocytes [#/volume] in Blood
43
302
1.46
1.49
3.1
3.5
e9/l
77.2
70.4
0.25
33
220
(3012516) Albumin [Mass/volume] in Urine
115
945
1.27
1.46
3.9
3.5
mg/l
769.2
279.2
0.31
71
644
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
442
4167
1.23
1.45
4.2
3.6
mmol/l
5.7
5.7
0.03
421
3845
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
28
2.52
1.45
3.0
2.5
u/ml
558.0
761.6
—
7
28
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
28
2.52
1.45
1.7
1.9
—
1224630.0
—
0
5
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
86
682
1.30
1.44
3.6
3.3
ng/l
56.2
616.5
2.72
61
443
(3003396) Base excess in Arterial blood by calculation
50
365
1.40
1.42
7.8
9.4
mmol/l
1.1
0.8
0.28
39
293
(3018133) Calcium [Moles/volume] in Urine
9
40
2.27
1.40
3.7
2.9
mmol/l
3.3
2.6
—
9
40
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
38
0.00
1.34
0.0
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
165
1426
1.22
1.33
1.9
1.8
pmol/l
100.7
97.4
0.36
91
730
(3002256) Pathology report gross observation
63
484
1.34
1.33
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
185
1.54
1.31
10.6
12.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
28
185
1.54
1.31
3.1
7.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
133
1126
1.23
1.31
1.6
1.7
mmol/l
1.4
1.3
0.53
110
999
(3041806) Other cells [#/volume] in Blood by Manual count
9
43
2.11
1.30
1.4
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
39
277
1.44
1.30
1.2
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
34
235
1.47
1.30
2.6
2.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
122
1024
1.24
1.30
3.3
3.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
179
1563
1.21
1.30
3.1
3.7
u/l
30.3
30.2
0.01
173
1487
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
59
452
1.34
1.27
1.5
1.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
44
2.06
1.27
1.3
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
58
445
1.34
1.24
4.5
4.6
%
1.8
1.6
0.53
51
413
(3017446) Testosterone [Moles/volume] in Serum or Plasma
51
386
1.35
1.20
3.2
2.1
nmol/l
11.0
12.6
0.62
42
349
(3013139) Helicobacter pylori Ag [Presence] in Stool
39
282
1.41
1.20
1.5
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
74
593
1.28
1.17
2.0
1.9
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
235
2120
1.18
1.17
5.0
6.4
umol/l
12.7
11.1
0.77
225
2001
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
87
1.74
1.16
1.4
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
87
1.74
1.16
1.4
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
523
5058
1.27
1.15
8.9
9.0
u/l
27.1
26.9
0.10
510
4900
(3009542) Hematocrit [Volume Fraction] of Blood
500
4813
1.24
1.14
13.6
12.2
%
40.0
40.4
0.56
382
3898
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
55
425
1.32
1.14
1.9
1.8
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
80
1.77
1.13
1.7
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
186
1649
1.19
1.13
5.8
6.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
157
1372
1.20
1.12
2.2
2.4
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
8
40
2.01
1.12
1.3
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
149
1296
1.20
1.12
4.2
3.6
mmol/l
7.7
8.4
0.80
131
1135
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
455
4345
1.20
1.10
4.4
4.1
mmol/l
2.7
2.8
0.83
432
4068
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
5
21
2.39
1.09
2.8
2.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
54
419
1.32
1.09
2.0
1.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
8
41
1.96
1.09
1.6
2.7
mmol/l
106.1
105.6
—
8
41
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
41
1.96
1.09
1.6
2.7
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
8
41
1.96
1.09
1.6
2.7
mmol/l
4.0
4.0
—
8
41
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
19
289
0.65
1.07
1.4
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
451
4310
1.19
1.05
4.0
3.8
mmol/l
4.6
4.6
1.10
428
4065
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
172
1.47
1.01
1.1
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
208
1877
1.17
1.01
3.2
2.6
nmol/l
74.5
72.0
0.58
196
1736
(3026389) Candida sp identified in Specimen by Organism specific culture
9
48
1.89
1.01
1.2
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
148
1301
1.18
0.99
2.8
3.1
ng/l
53.5
34.5
0.37
77
723
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
65
525
1.27
0.99
3.1
2.7
%
23.5
24.8
0.34
53
469
(3018418) pH of Serum or Plasma
128
1111
1.19
0.99
5.0
3.8
ph
7.4
7.4
0.01
18
191
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
23
2.18
0.98
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
186
0.58
0.97
1.2
1.2
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
31
0.00
0.96
0.0
2.9
—
47.2
—
0
31
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.0
—
200.2
—
0
31
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
193
1738
1.16
0.96
3.7
3.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
60
482
1.27
0.96
3.8
7.2
mmol/l
1.8
1.5
0.26
50
378
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
86
721
1.23
0.95
2.1
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
73
603
1.24
0.93
1.9
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
447
4285
1.17
0.92
3.9
3.7
mmol/l
1.4
1.5
0.63
423
4020
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
170
0.58
0.91
3.1
2.2
—
—
—
0
0
(4010399)
38
289
1.34
0.90
1.7
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
187
1687
1.16
0.90
2.9
2.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
101
0.49
0.90
1.0
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
148
1312
1.17
0.90
3.3
2.9
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
70
578
1.24
0.89
2.9
2.6
g/l
2.5
2.4
0.13
65
541
(3017732) Neutrophils [#/volume] in Blood
40
308
1.32
0.88
2.0
2.4
e9/l
4.0
4.0
0.05
31
264
(3001122) Ferritin [Mass/volume] in Serum or Plasma
251
2316
1.14
0.88
3.3
2.9
ug/l
179.6
84.2
0.43
234
2174
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
64
1.73
0.86
1.2
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
76
636
1.22
0.86
2.9
2.6
umol/l
14.4
14.6
0.10
70
593
(3015377) Calcium [Moles/volume] in Serum or Plasma
146
1298
1.17
0.85
2.7
3.0
mmol/l
2.4
2.4
0.80
132
1163
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
342
3227
1.14
0.85
3.0
3.4
u/l
40.0
38.8
0.10
331
3072
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
94
806
1.20
0.84
3.9
3.4
ng/l
990.4
767.5
0.32
76
673
(3034770) Mitochondria Ab [Titer] in Serum
8
140
0.57
0.84
1.1
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
8
140
0.57
0.84
1.3
1.5
—
55.7
—
0
14
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
6
114
0.52
0.83
1.2
1.1
—
11.3
—
0
5
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
46
1.75
0.82
1.0
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
6
32
1.88
0.82
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
8
47
1.71
0.81
2.0
1.2
—
—
—
0
0
(3000492) Spirometry study
56
458
1.25
0.79
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
67
559
1.22
0.79
1.7
1.6
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
24
0.00
0.79
0.0
5.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
24
0.00
0.79
0.0
1.0
—
1490.0
—
0
24
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
24
0.00
0.79
0.0
2.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
8
48
1.68
0.79
2.0
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
48
1.68
0.79
1.1
1.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
14
90
1.57
0.78
3.0
3.6
mg/l
16.2
29.3
—
7
55
(3037121) Protein [Mass/volume] in Urine
26
192
1.37
0.76
4.2
6.4
g/l
0.2
0.3
1.25
16
115
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
165
1493
1.15
0.76
1.6
1.5
u/ml
1.6
2.5
0.48
33
359
(40761511) CBC panel - Blood by Automated count
528
5155
1.21
0.76
11.6
9.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
299
2811
1.13
0.76
7.2
9.3
e9/l
3.7
3.8
0.55
262
2436
(1002224) Polysomnography panel
14
208
0.67
0.75
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
40
1.76
0.71
4.0
5.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
26
1.93
0.70
1.2
1.2
—
—
—
0
0
(4062490)
9
59
1.53
0.68
1.1
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
27
1.86
0.68
7.4
9.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
428
4126
1.13
0.68
3.5
3.4
mmol/l
1.3
1.2
0.15
403
3870
(36660697) Celiac disease serology panel - Serum
65
551
1.20
0.68
1.1
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
14
94
1.50
0.67
1.9
1.4
u/l
9.2
18.8
1.61
14
80
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
28
1.79
0.66
1.0
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
257
2413
1.11
0.64
6.1
6.7
%
54.1
54.7
0.40
246
2291
(3032773) Endomysium IgG Ab [Titer] in Serum
13
87
1.51
0.63
1.5
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
12
79
1.53
0.63
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
567
5591
1.27
0.62
17.6
16.3
e9/l
253.2
257.8
1.01
555
5434
(3013115) Eosinophils [#/volume] in Blood
270
2546
1.11
0.62
6.0
7.2
e9/l
0.2
0.2
0.24
237
2252
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
65
557
1.19
0.61
1.8
1.9
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
5
30
1.67
0.61
1.0
1.7
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
30
1.67
0.61
5.4
6.7
—
33.5
—
0
8
(3022096) Basophils/100 leukocytes in Blood
242
2271
1.11
0.60
6.4
7.0
%
0.7
0.7
0.60
229
2145
(3022806) Fractional oxyhemoglobin in Capillary blood
8
52
1.55
0.59
1.9
1.8
%
92.3
90.8
—
8
52
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
53
1.52
0.58
2.4
3.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
103
922
1.14
0.57
1.4
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
296
0.77
0.57
1.6
2.7
ml/min/173m2
84.6
73.6
—
7
121
(3050129) First trimester maternal screen panel - Serum or Plasma
27
340
0.78
0.56
1.4
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
33
267
1.25
0.55
1.5
1.6
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
567
5599
1.24
0.53
17.5
16.3
e12/l
4.6
4.6
0.62
553
5433
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
44
521
0.83
0.53
1.4
1.5
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
39
1.54
0.53
2.7
2.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
416
1.19
0.53
2.3
2.4
u/l
31.2
148.3
0.52
41
358
(3002030) Lymphocytes/100 leukocytes in Blood
259
2454
1.10
0.52
6.3
6.8
%
31.5
30.7
0.63
246
2327
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
9
136
0.66
0.52
1.8
1.3
—
26.7
—
0
6
(3010813) Leukocytes [#/volume] in Blood
567
5601
1.24
0.51
17.6
16.3
e9/l
6.6
6.7
0.10
552
5431
(4027681)
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
64
1.41
0.51
2.6
7.7
%
61.2
66.7
—
9
64
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
109
1.39
0.51
1.9
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
116
1055
1.12
0.51
2.2
2.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
92
1.42
0.51
4.8
3.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
722
1.14
0.49
3.6
3.1
e6/l
0.7
1.1
0.88
47
402
(42529406) Shigella sp [Presence] in Stool by Culture
11
155
0.70
0.49
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
190
1.27
0.48
1.1
1.2
u/ml
0.3
2.1
1.77
13
97
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
169
1574
1.10
0.48
2.1
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
46
1.53
0.48
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
7
46
1.53
0.48
1.1
1.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
398
4101
0.91
0.48
10.8
9.5
ml/min/173m2
92.8
92.6
0.07
307
3197
(3019225) pH of Specimen
39
328
1.20
0.47
4.0
3.9
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
269
2564
1.09
0.47
6.0
6.8
e9/l
1.9
2.0
0.72
235
2271
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
18
232
0.77
0.46
1.4
1.6
mg/l
1.9
3.3
1.79
13
155
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
142
0.70
0.46
2.0
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
94
1.39
0.46
4.4
2.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
77
1.44
0.46
2.3
7.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
53
606
0.86
0.44
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
17
219
0.77
0.44
1.3
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
45
521
0.85
0.44
2.7
2.7
ug/l
0.7
0.7
0.02
27
307
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
51
1.38
0.44
1.3
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
95
1.38
0.44
1.2
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
21
166
1.27
0.44
1.1
1.2
u/ml
8.8
2.3
—
5
39
(3001019) Free T4 and TSH panel - Serum or Plasma
33
276
1.21
0.43
1.6
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
11
151
0.72
0.43
1.1
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
50
435
1.16
0.43
9.3
10.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
107
980
1.11
0.43
2.6
2.9
umol/l
343.3
5938.2
3.54
99
875
(3023183) Ammonium ion [Moles/volume] in Plasma
6
91
0.66
0.42
1.8
4.7
umol/l
28.2
35.6
—
6
80
(3042631) Mycobacterium sp identified in Specimen
5
32
1.57
0.42
2.8
3.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
32
1.57
0.42
1.4
1.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
21
168
1.26
0.40
1.0
1.2
u/ml
3.9
0.6
0.43
14
104
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
11
149
0.73
0.40
1.1
1.1
—
—
—
0
0
(4146454)
5
34
1.47
0.40
2.6
2.9
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
258
2468
1.08
0.40
6.0
6.8
e9/l
0.5
0.5
0.68
222
2137
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
105
1139
0.91
0.39
4.8
4.9
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
35
1.43
0.39
1.4
2.4
nmol/l
17.8
2.8
—
5
35
(40768446) Kidney Pathology biopsy report
5
35
1.43
0.39
2.4
2.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
20
247
0.80
0.38
1.3
1.4
miu/ml
206.5
259.7
0.38
11
120
(3023511) Choriogonadotropin [Units/volume] in Urine
26
215
1.22
0.38
1.5
1.3
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
5
36
1.39
0.38
1.0
1.1
—
1.1
—
0
14
(3017143) Hepatitis C virus Ab [Presence] in Serum
87
794
1.11
0.38
1.8
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
37
318
1.17
0.37
5.0
6.6
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
245
2345
1.08
0.37
6.3
6.9
%
3.0
3.0
0.08
233
2208
(3006315) Basophils [#/volume] in Blood
258
2477
1.07
0.36
6.0
6.8
e9/l
0.0
0.0
0.21
222
2144
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
42
1.43
0.35
1.0
1.0
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
246
2359
1.07
0.35
6.4
7.1
%
8.5
8.3
0.34
235
2235
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
520
1.13
0.34
2.4
4.8
umol/l
17.3
8.3
0.44
50
454
(3026008) Bacteria identified in Urine by Culture
126
1178
1.09
0.34
3.8
2.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
44
1.37
0.34
1.3
1.4
—
—
—
0
0
(44813793)
6
44
1.37
0.34
1.2
1.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
114
1062
1.09
0.34
2.0
2.1
u/l
361.4
270.8
0.16
105
1009
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
88
0.68
0.33
1.2
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
164
1.23
0.33
2.0
1.7
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
128
1201
1.08
0.32
2.3
2.3
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
6
47
1.28
0.32
1.0
1.1
mg/l
33.5
30.4
—
6
39
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
47
1.28
0.32
1.7
1.3
nmol/l
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
83
1.33
0.32
4.4
3.8
kpa
9.1
9.0
0.04
11
83
(3013290) Carbon dioxide [Partial pressure] in Blood
11
83
1.33
0.32
8.1
3.8
kpa
5.0
5.0
0.02
11
83
(3003888) Timothy IgE Ab [Units/volume] in Serum
21
174
1.21
0.32
1.1
1.2
u/ml
14.6
8.1
0.64
15
120
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
197
0.81
0.31
2.6
1.5
g/l
1.1
1.2
0.52
16
188
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
32
368
0.86
0.31
1.3
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
49
439
1.13
0.30
3.4
3.8
%
31.9
31.6
0.07
41
309
(3000330) Specific gravity of Urine by Test strip
21
175
1.21
0.30
4.4
3.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
430
0.88
0.30
7.7
5.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
97
904
1.09
0.29
4.6
4.2
ug/l
1.7
1.8
0.16
88
810
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
110
0.72
0.29
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
16
130
1.24
0.29
2.4
3.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
57
1.23
0.29
2.1
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
25
291
0.85
0.29
3.0
4.0
ug/l
2.8
32.8
1.00
16
225
(3017181) Myelocytes/100 leukocytes in Blood
41
365
1.13
0.28
4.0
5.1
%
0.2
0.8
—
10
111
(3009445) Proteinase 3 Ab [Units/volume] in Serum
22
186
1.19
0.28
1.7
1.4
—
9.7
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
11
85
1.30
0.28
5.8
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
132
1250
1.07
0.27
4.7
7.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
8
67
1.20
0.26
4.4
6.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
77
1.30
0.26
1.6
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
38
339
1.13
0.26
4.2
5.4
%
0.0
0.1
—
8
96
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
12
149
0.80
0.26
1.6
2.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
192
0.83
0.26
2.6
1.5
g/l
0.2
0.2
0.57
16
185
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
138
0.79
0.26
1.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
90
842
1.08
0.25
1.7
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
35
392
0.89
0.25
1.1
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
41
454
0.90
0.24
2.5
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
189
1.17
0.24
2.2
2.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
87
1.27
0.24
8.7
4.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
114
1203
0.94
0.24
1.8
1.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
78
1.29
0.24
1.4
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
81
0.74
0.24
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
284
1.13
0.24
1.8
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
85
0.70
0.24
3.0
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
83
777
1.08
0.23
1.2
1.2
u/ml
9.6
10.3
0.03
34
315
(3027008) Opiates [Presence] in Urine
41
452
0.90
0.23
2.7
1.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
116
1221
0.94
0.23
3.9
3.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
41
451
0.90
0.22
2.7
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
18
210
0.85
0.22
2.1
2.5
u/ml
15.9
43.7
1.51
18
200
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
21
182
1.16
0.21
1.5
1.6
u/ml
176.1
221.1
0.61
14
96
(42870560) Thyrotropin [Units/volume] in Cord blood
0
11
0.00
0.21
0.0
1.0
—
18.4
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
11
0.00
0.21
0.0
1.4
—
456.2
—
0
6
(3011436) Histone Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
16.8
—
0.4
—
0
11
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
11.1
—
0
10
(3004959) Base excess in Arterial cord blood by calculation
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(4094501)
12
98
1.23
0.21
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
125
1193
1.06
0.21
3.9
3.4
estimate
0.0
0.0
0.88
38
456
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
8
101
0.79
0.21
1.1
1.9
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
15
177
0.84
0.21
1.5
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
41
449
0.91
0.21
2.5
1.8
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
5
43
1.16
0.21
28.4
33.7
ug/l
6.1
6.6
—
5
35
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
117
1115
1.06
0.21
2.3
2.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
128
1338
0.94
0.21
4.1
3.5
e6/l
54.9
99.8
0.36
102
1015
(3013637) Mi-2 Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
42
384
1.10
0.20
5.1
6.3
mmol/l
1.4
1.7
0.22
29
269
(40761535) Cells panel - Urine sediment
26
292
0.89
0.20
4.2
3.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
48
1.25
0.20
2.0
2.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
29
260
1.12
0.19
1.7
2.1
ug/l
6.5
8.9
0.28
23
233
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
2.2
1.7
—
—
—
0
0
(4198724)
6
52
1.16
0.19
1.0
1.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
81
1.24
0.19
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
11
91
1.21
0.17
1.5
2.3
—
—
—
0
0
(3013512) EKG study
104
994
1.06
0.17
3.8
3.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
39
423
0.92
0.17
2.6
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
100
956
1.06
0.17
1.6
2.2
mg/l
1.2
1.1
0.03
75
707
(44790047)
8
68
1.18
0.16
1.0
1.7
—
—
—
0
0
(44806118)
8
68
1.18
0.16
1.0
1.7
—
—
—
0
0
(44790049)
8
68
1.18
0.16
1.0
1.7
—
—
—
0
0
(44790048)
8
68
1.18
0.16
1.0
1.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
162
0.86
0.16
1.4
1.6
—
0.0
—
0
37
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
16
183
0.87
0.16
1.5
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
63
667
0.94
0.16
1.5
1.4
titre
613.3
507.0
—
9
132
(3039443) Prostate specific Ag panel - Serum or Plasma
6
79
0.76
0.15
1.5
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
148
1528
0.96
0.15
4.3
3.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
80
1.13
0.15
1.8
1.7
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
9
81
1.11
0.15
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
81
1.11
0.15
2.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
10
118
0.84
0.14
2.2
1.8
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
24
264
0.91
0.14
1.2
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
24
264
0.91
0.14
1.2
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
27
295
0.91
0.14
1.3
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
324
1.09
0.14
4.4
5.4
%
0.0
0.0
—
7
82
(3002179) Metamyelocytes/100 leukocytes in Blood
36
334
1.08
0.14
4.5
4.8
%
0.0
0.4
—
5
75
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
189
1.12
0.14
1.5
1.6
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
103
1.17
0.14
7.4
8.0
u/ml
—
2901.9
—
0
9
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
24
263
0.91
0.13
1.2
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
24
263
0.91
0.13
1.2
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
43
403
1.07
0.13
11.1
10.2
mmol/l
24.7
25.0
0.25
43
403
(3048929) Epstein Barr virus Ab [Presence] in Serum
39
364
1.08
0.13
1.5
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
156
1603
0.96
0.13
1.6
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
82
786
1.05
0.13
3.2
2.6
ug/g
189.2
110.5
1.04
66
620
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
45
423
1.07
0.13
1.3
1.3
iu/ml
100.2
144.5
0.66
21
174
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
106
0.85
0.13
1.7
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
129
1330
0.96
0.13
1.7
1.4
g/l
1.8
2.1
1.44
78
780
(3030467) Casts [#/volume] in Urine by Automated count
118
1218
0.96
0.12
4.1
3.4
e6/l
0.5
0.3
0.41
93
901
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
19
171
1.11
0.12
1.7
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
11
127
0.86
0.12
3.4
3.2
u/ml
614.1
1844.6
0.44
11
107
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
158
0.88
0.12
2.1
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
21
191
1.10
0.12
1.2
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
114
1.14
0.12
1.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
152
1482
1.03
0.11
2.3
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
86
1.17
0.11
2.8
2.6
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
115
1.13
0.10
1.5
1.4
ug/g
256.5
324.7
—
8
62
(3000850) Epithelial cells [#/volume] in Urine
94
910
1.04
0.10
2.8
2.7
e6/l
6.3
6.8
0.12
88
802
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
82
792
1.04
0.10
1.2
1.2
iu/ml
16.0
28.0
1.53
31
239
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
193
1.09
0.10
1.7
1.7
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
114
0.88
0.09
1.6
2.4
ug/l
167.1
274.3
—
10
104
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
155
1.10
0.09
1.5
1.6
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
49
512
0.95
0.09
1.3
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
57
593
0.96
0.09
2.1
2.4
mmol/l
2.5
2.4
0.79
51
508
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
12
134
0.89
0.09
1.1
2.4
mg/l
401.5
456.3
0.34
12
127
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
185
1.08
0.08
1.4
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
65
0.77
0.08
1.4
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
123
0.89
0.08
2.3
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
66
1.06
0.08
1.1
1.5
—
—
—
0
0
(4306422)
7
67
1.05
0.08
1.0
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
24
256
0.93
0.08
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
68
1.03
0.08
1.1
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
98
1.12
0.07
2.8
5.2
u/ml
0.2
0.3
—
5
54
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
70
0.86
0.07
2.8
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
70
0.86
0.07
1.3
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
74
718
1.03
0.07
4.3
3.9
%
21.7
21.5
0.04
32
301
(3023368) Bacteria identified in Blood by Culture
98
956
1.03
0.07
4.9
4.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
2.0
1.7
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
76
1.05
0.07
2.0
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
20
186
1.08
0.07
2.1
5.0
g/l
3.1
3.3
0.27
20
180
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
112
0.89
0.07
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
97
947
1.03
0.07
2.0
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
7
82
0.85
0.07
12.1
4.7
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
11
122
0.90
0.07
1.1
2.4
mmol/l
3.5
3.6
0.48
11
116
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
101
0.89
0.06
4.4
4.2
%
50.8
54.2
—
9
101
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
100
0.90
0.06
3.6
3.6
e9/l
3.2
4.1
—
9
100
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
102
0.88
0.06
1.1
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
17
158
1.08
0.06
1.8
1.7
—
231.4
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
34
355
0.96
0.06
2.9
1.9
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
375
0.96
0.06
1.2
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
17
182
0.93
0.05
1.6
2.0
—
—
—
0
0
(4034850)
15
139
1.08
0.05
16.2
7.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
38
366
1.04
0.05
2.3
2.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
40
414
0.96
0.05
4.8
3.6
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
72
736
0.98
0.05
1.5
1.7
%
1.4
1.4
0.07
64
666
(44816559) Phosphatidylethanol [Mass/volume] in Blood
12
130
0.92
0.04
1.3
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
11
119
0.92
0.04
2.1
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
71
698
1.02
0.03
3.9
3.2
e6/l
2.3
3.1
0.69
39
381
(3014148) Varicella zoster virus Ab [Titer] in Serum
11
102
1.08
0.03
1.0
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
229
2278
1.01
0.02
8.3
8.9
e9/l
0.0
0.0
0.68
184
1817
(3028707) Methadone [Presence] in Urine by Screen method
21
218
0.96
0.02
4.0
2.2
—
—
—
0
0
(4035726)
28
288
0.97
0.02
1.6
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
159
1600
0.99
0.01
4.3
4.0
e6/l
48.4
62.9
0.39
111
1091
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
21
203
1.04
0.01
2.0
4.7
%
96.2
91.4
0.65
21
198
(3021879) Hepatitis B virus core Ab [Presence] in Serum
51
503
1.02
0.01
1.5
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
164
1.04
0.00
1.8
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
24
246
0.97
0.00
1.5
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
39
384
1.02
0.00
2.4
2.4
u/l
14076.4
4450.0
0.36
14
150
(3026782) Osmolality of Urine
87
876
0.99
0.00
3.0
2.8
mosm/kgh2o
567.6
575.6
0.11
74
758
(3049717) Cytology report of Urine Cyto stain
11
105
1.05
0.00
1.6
2.4
—
—
—
0
0
(3020891) Body temperature
12
125
0.96
0.00
6.3
4.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
22
224
0.98
0.00
1.8
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
31
306
1.01
0.00
1.2
1.2
—
41.9
—
0
15
(3036489) Thrombin time
21
207
1.02
0.00
1.9
4.2
s
21.9
22.3
0.18
16
190
(3043238) Trisomy 21 risk [Likelihood] in Fetus
22
217
1.01
0.00
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
118
1.02
0.00
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
15
152
0.99
0.00
2.1
1.7
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
166
1655
1.00
0.00
2.1
1.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
212
0.99
0.00
1.2
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
31
312
0.99
0.00
3.6
2.3
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
40
402
0.99
0.00
3.9
4.4
u/l
271.1
238.1
0.56
40
387
(3044290) Cell count panel - Cerebral spinal fluid
11
109
1.01
0.00
1.0
2.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
121
0.99
0.00
1.3
1.1
u/ml
2.4
6.3
—
7
48
(3005033) Fetal Nuchal fold Thickness US
21
211
1.00
0.00
1.2
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
58
579
1.00
0.00
1.7
2.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
87
0.92
0.00
1.5
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
49
1.02
0.00
1.0
2.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4268621)
5
58
0.86
0.00
3.2
2.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
7
78
0.90
0.00
5.3
5.3
umol/l
439.3
378.4
—
7
73
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
67
0.89
0.00
2.2
1.5
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.0
—
250.0
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
150
1.00
0.00
1.1
1.1
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.4
—
56.8
—
0
5
(3025315) Body weight
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
6
0.00
0.00
0.0
2.2
—
9.8
—
0
6
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.8
—
50.0
—
0
6
(3040893) Potassium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
5.0
—
4.1
—
0
5
(3021788) Differential panel - Synovial fluid
5
52
0.96
0.00
1.4
1.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
22
220
1.00
0.00
1.5
1.4
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
6
65
0.92
0.00
2.7
4.0
%
3.0
1.2
—
6
53
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
6
0.00
0.00
0.0
2.5
—
291.3
—
0
6
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
66
0.91
0.00
1.2
1.3
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
50
1.00
0.00
1.8
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022670) pH of Venous cord blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
60
1.00
0.00
2.0
5.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
25.1
—
0
8
(3012898) Urea [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
229.3
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
33.4
—
0
8
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
69
0.87
0.00
2.3
1.6
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
25.7
—
0
9
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint K11_MN_PROGN and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_MN_PROGN | 0.831 [0.63, 1.1] | 0.196 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 58 out of 4813 males with K11_MN_PROGN died.
Mortality risk
Mortality risk for people of age
years, who have K11_MN_PROGN.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.156% |
| 5 | No data | 0.989% |
| 10 | No data | 2.462% |
| 15 | No data | 4.535% |
| 20 | No data | 7.645% |
Relationships between endpoints
↥Index endpoint: K11_MN_PROGN – Mandibular prognathia
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data